Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hermann Ahlen
Long Term Progression Free Survival Achieved by Maintenance “Second–Line” Polychemotherapy With Gemcitabine/Paclitaxel in Metastatic Urothelial Cancer of the Renal Pelvis—A Case Report
Journal of Cancer Therapy
Related publications
Triplet Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin as Second-Line Therapy for Advanced Urothelial Carcinoma
Modern Chemotherapy
Phase II Study of Second-Line Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin for Advanced Urothelial Carcinoma
Anticancer Research
Medicine
Cancer Research
Oncology
Front-Line Treatment With Gemcitabine, Paclitaxel, and Doxorubicin for Patients With Unresectable or Metastatic Urothelial Cancer and Poor Renal Function: Final Results From a Phase II Study
Urology
Urology
Extended Progression-Free Survival of Renal Cell Carcinoma With Axitinib: Case Report
Journal of Urology and Renal Diseases
Long-Term Survival in a Case of Renal Cell Carcinoma With Brain Metastases: A Case Report
Clinical Medicine Insights: Case Reports
Medicine
Long-Term Survival in a Patient With Metastatic Squamous Cell Lung Carcinoma: A Case Report
Molecular and Clinical Oncology
Cancer Research
Oncology
Long-Term Progression-Free Survival of Third-Line Apatinib in Lung Squamous Cell Carcinoma
OncoTargets and Therapy
Oncology
Pharmacology
Genetic Polymorphisms Associated With a Prolonged Progression-Free Survival in Patients With Metastatic Renal Cell Cancer Treated With Sunitinib
Clinical Cancer Research
Cancer Research
Oncology
Long‑term Survival in a Recipient of Kidney Transplant Without Maintenance Immunosuppression: A Case Report
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
